Download: Considerations for Biopharmaceuticals and Implications for Biosimilars

Genzyme photo

 

At last years BioPharma India conference Shekar Ganesa, Senior Director, Analytical Development, Genzyme-Sanofi delivered the presentation:  Analytical Considerations for Biopharmaceuticals and its Implications for Biosimilars.

Click here to download the presentation

This presenation explores:

• Complexity of Biologics
• FDA Draft Guidance on Biosimilars
• Comparability – What does that mean?
• Examples and Analytical Methods Used to monitor PTM's
• Emerging Technologies

Click here to download the presentation

 

If you found this presentation interesting then you may also be interested in our BioPharma India 2013 event. Click here to visit the event website

Leave a Reply

Your email address will not be published. Required fields are marked *